Concepta PLC Appointment China Country Manager

TIDMCPT

Concepta PLC

08 December 2016

8 December 2016

Concepta plc ("Concepta" or "the Company")

Appointment of China Country Manager Ahead of myLotus Fertility Product Launch

Concepta plc (AIM:CPT), the UK healthcare company targeting the personalised mobile health market with a primary focus on women's fertility, is pleased to announce that it has appointed Kevin Su Wei as its China Country Manager, based in Shanghai, with immediate effect. This appointment is in line with the Company's strategy of launching its myLotus product, targeted at women with unexplained infertility* into its first international market, China, early 2017.

Mr Su Wei has over 10 years' sales, distribution and opinion leader management experience in healthcare and specifically women's health. He has held management positions at Merck Millipore, the life sciences division of global healthcare player Millipore corporation and at Inverness Medical (now Alere), a leading innovative global diagnostics company.

At Concepta Kevin will build Concepta's distributor network and lead the set up of Concepta's Chinese subsidiary in line with the Company's growth projections. Kevin's past experience in China and with fertility products ideally positions him to build Concepta's brand and product presence in China.

Erik Henau, CEO of Concepta says: "We are delighted to welcome Kevin as part of our Chinese division here at Concepta. He brings with him a wealth of experience both in healthcare and specifically the women's healthcare market in China that will be invaluable to Concepta as we look to launch our myLotus fertility product in the country early 2017. We look forward to updating the market in due course on the myLotus launch into China and our on-going developments in the UK and Europe as we target the product launch into our second international market towards the end of 2017."

ENDS

Enquiries:

The Company

Adam Reynolds, Chairman

Tel: [phone]

SPARK Advisory Partners Limited (Nomad)

Neil Baldwin/Mark Brady

Tel: [phone]

Beaufort Securities Limited (Broker)

Jon Belliss

Tel: [phone]

Yellow Jersey PR Limited (Financial PR)

Felicity Winkles/ Joe Burgess

Tel: [phone]

About Concepta Plc:

Concepta plc is a pioneering UK healthcare company that has developed a proprietary platform and products targeted at the personalised mobile health market with a primary focus on women's fertility and specifically unexplained infertility*.

Founded in 2013, Concepta has developed a revolutionary flagship product 'myLotus' for home self-testing that helps women with unexplained infertility to conceive.

myLotus is the only consumer product which allows both quantitative and qualitative measurements of measurement of a woman's personal hCG and LH hormone levels in an easy to use home test to facilitate higher conception rates and early diagnosis of any fertility problems. Competitor products currently only allow qualitative measurement and are based on the 'average woman'.

Concepta has a defined route to market for its new 'my Lotus' product with Regulatory approvals for launch in China in place for 2016 and CE-Marking for UK and Europe to follow in 2017 where the revenue potential of the Chinese and EU infertility market is worth c.GBP600m per annum for the company.

*Unexplained infertility refers to women that have been unable to conceive after 6 months of trying. This highly motivated target group of consumers won't typically be offered medical intervention until 12 months of unsuccessfully trying, with IVF not offered until two years. Research indicates couples start to take positive action ahead of this time and there is little medical support to help them do so.

This information is provided by RNS

The company news service from the London Stock Exchange

END

NRAQVLBBQLFXFBX

(END) Dow Jones Newswires

December 08, 2016 02:00 ET (07:00 GMT)